Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07885436
NA

68Ga-XHER2 PET/CT for HER2 Assessment

Sponsor: The First Affiliated Hospital of Xiamen University

View on ClinicalTrials.gov

Summary

The objective of this study is to evaluate the feasibility of 68Ga-XHER2 PET/CT as a noninvasive imaging approach for assessing HER2 expression in patients with solid tumors and to investigate the correlation between tracer uptake and pathological HER2 expression.

Official title: 68Ga-XHER2 PET/CT for Noninvasive Assessment of HER2 Expression Across Solid Tumors

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2026-10-22

Completion Date

2027-10-22

Last Updated

2026-10-21

Healthy Volunteers

Yes

Interventions

DRUG

68Ga-XHER2 PET/CT

Each participant will receive a single intravenous injection of 68Ga-XHER2, a novel HER2-targeted PET probe, followed by PET/CT imaging.

Locations (1)

The First Affiliated Hospital of Xiamen University

Xiamen, Fujian, China